- Home
- Publications
- Publication Search
- Publication Details
Title
Ductal Carcinoma In Situ Biology, Biomarkers, and Diagnosis
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 7, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2017-10-23
DOI
10.3389/fonc.2017.00248
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prognostic significance of tumour infiltrating B lymphocytes in breast ductal carcinoma in situ
- (2017) Islam Miligy et al. HISTOPATHOLOGY
- Multigene Expression Assay and Benefit of Radiotherapy After Breast Conservation in Ductal Carcinoma in Situ
- (2017) Eileen Rakovitch et al. JNCI-Journal of the National Cancer Institute
- Breast ductal carcinoma in situ carry mutational driver events representative of invasive breast cancer
- (2017) Jia-Min B Pang et al. MODERN PATHOLOGY
- Whole-genome single-cell copy number profiling from formalin-fixed paraffin-embedded samples
- (2017) Luciano G Martelotto et al. NATURE MEDICINE
- Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy
- (2017) Teresa Davoli et al. SCIENCE
- Multigene Expression Assay and Benefit of Radiotherapy After Breast Conservation in Ductal Carcinoma in Situ
- (2017) Eileen Rakovitch et al. JNCI-Journal of the National Cancer Institute
- An Examination of the Local Cellular Immune Response to Examples of Both Ductal Carcinoma In Situ (DCIS) of the Breast and DCIS With Microinvasion, With Emphasis on Tertiary Lymphoid Structures and Tumor Infiltrating Lymphoctytes
- (2016) Ahrong Kim et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- The prevalence and clinical relevance of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ of the breast
- (2016) G. Pruneri et al. ANNALS OF ONCOLOGY
- Clinical Utility of the 12-Gene DCIS Score Assay: Impact on Radiotherapy Recommendations for Patients with Ductal Carcinoma In Situ
- (2016) Jennifer B. Manders et al. ANNALS OF SURGICAL ONCOLOGY
- Risk prediction for local versus regional/metastatic tumors after initial ductal carcinoma in situ diagnosis treated by lumpectomy
- (2016) Annette M. Molinaro et al. BREAST CANCER RESEARCH AND TREATMENT
- Characterizing the immune microenvironment in high-risk ductal carcinoma in situ of the breast
- (2016) Michael J. Campbell et al. BREAST CANCER RESEARCH AND TREATMENT
- Extent of ductal carcinoma in situ according to breast cancer subtypes: a population-based cohort study
- (2016) Shusma C. Doebar et al. BREAST CANCER RESEARCH AND TREATMENT
- Predictors for local invasive recurrence of ductal carcinoma in situ of the breast
- (2016) Xining Zhang et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- Further evidence to support bimodality of oestrogen receptor expression in breast cancer
- (2016) Abir A Muftah et al. HISTOPATHOLOGY
- Cause-specific mortality in women with breast cancerin situ
- (2016) Wei He et al. INTERNATIONAL JOURNAL OF CANCER
- Cost Effectiveness of the Oncotype DX DCIS Score for Guiding Treatment of Patients With Ductal Carcinoma In Situ
- (2016) Ann C. Raldow et al. JOURNAL OF CLINICAL ONCOLOGY
- Patient Prognostic Score and Associations With Survival Improvement Offered by Radiotherapy After Breast-Conserving Surgery for Ductal Carcinoma In Situ: A Population-Based Longitudinal Cohort Study
- (2016) Yasuaki Sagara et al. JOURNAL OF CLINICAL ONCOLOGY
- Screen detection of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers: a retrospective population-based study
- (2016) Stephen W Duffy et al. LANCET ONCOLOGY
- The immune microenvironment of breast ductal carcinoma in situ
- (2016) Elizabeth Thompson et al. MODERN PATHOLOGY
- Tamoxifen Initiation After Ductal Carcinoma In Situ
- (2016) H. B. Nichols et al. ONCOLOGIST
- Molecular Features of Subtype-Specific Progression from Ductal Carcinoma In Situ to Invasive Breast Cancer
- (2016) Robert Lesurf et al. Cell Reports
- Her2 and Ki67 Biomarkers Predict Recurrence of Ductal Carcinoma in Situ
- (2016) James E. Davis et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- Molecular phenotypes of DCIS predict overall and invasive recurrence
- (2015) K. E. Williams et al. ANNALS OF ONCOLOGY
- Risk of subsequent in situ and invasive breast cancer in human epidermal growth factor receptor 2-positive ductal carcinoma in situ
- (2015) G. Curigliano et al. ANNALS OF ONCOLOGY
- Relationship Between Margin Width and Recurrence of Ductal Carcinoma In Situ
- (2015) Kimberly J. Van Zee et al. ANNALS OF SURGERY
- Risk Prediction for Local Breast Cancer Recurrence Among Women with DCIS Treated in a Community Practice: A Nested, Case–Control Study
- (2015) Laura C. Collins et al. ANNALS OF SURGICAL ONCOLOGY
- Long-term outcomes of ductal carcinoma in situ of the breast: a systematic review, meta-analysis and meta-regression analysis
- (2015) Kirsty E. Stuart et al. BMC CANCER
- A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone
- (2015) Eileen Rakovitch et al. BREAST CANCER RESEARCH AND TREATMENT
- Cancer statistics: Breast cancer in situ
- (2015) Elizabeth M. Ward et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A Molecular Portrait of High-Grade Ductal Carcinoma In Situ
- (2015) Martin C. Abba et al. CANCER RESEARCH
- Addressing Overtreatment in DCIS: What Should Physicians Do Now?
- (2015) Monica Morrow et al. JNCI-Journal of the National Cancer Institute
- Trends in Treatment Patterns and Outcomes for Ductal Carcinoma In Situ
- (2015) Mathias Worni et al. JNCI-Journal of the National Cancer Institute
- Correlation of histopathologic features of ductal carcinoma in situ of the breast with the oncotype DX DCIS score
- (2015) Adriana Knopfelmacher et al. MODERN PATHOLOGY
- Copy number analysis of ductal carcinoma in situ with and without recurrence
- (2015) Kylie L Gorringe et al. MODERN PATHOLOGY
- Genomic differences between pure ductal carcinoma in situ and synchronous ductal carcinoma in situ with invasive breast cancer
- (2015) Shinn Young Kim et al. Oncotarget
- DNA methylation in ductal carcinoma in situ related with future development of invasive breast cancer
- (2015) Kevin C. Johnson et al. Clinical Epigenetics
- Addressing Overtreatment in DCIS: What Should Physicians Do Now?
- (2015) Monica Morrow et al. JNCI-Journal of the National Cancer Institute
- Trends in Treatment Patterns and Outcomes for Ductal Carcinoma In Situ
- (2015) Mathias Worni et al. JNCI-Journal of the National Cancer Institute
- Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ
- (2015) Steven A. Narod et al. JAMA Oncology
- Risk of subsequent invasive breast cancer after a diagnosis of ductal carcinoma in situ (DCIS)
- (2014) Shan Cheung et al. BREAST
- COX-2 expression is predictive for early relapse and aromatase inhibitor resistance in patients with ductal carcinoma in situ of the breast and is a target for treatment
- (2014) D Generali et al. BRITISH JOURNAL OF CANCER
- Local Relapse After Breast-Conserving Therapy for Ductal Carcinoma In Situ
- (2014) Caroline Sweldens et al. CANCER JOURNAL
- v 6 Expression in Myoepithelial Cells: A Novel Marker for Predicting DCIS Progression with Therapeutic Potential
- (2014) M. D. Allen et al. CANCER RESEARCH
- Validation of a Nomogram in the Prediction of Local Recurrence Risks after Conserving Surgery for Asian Women with Ductal Carcinoma in Situ of the Breast
- (2014) F. Wang et al. CLINICAL ONCOLOGY
- Stromal Fibroblasts and the Immune Microenvironment: Partners in Mammary Gland Biology and Pathology?
- (2014) Ashleigh Unsworth et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Continued observation of the natural history of low-grade ductal carcinoma in situ reaffirms proclivity for local recurrence even after more than 30 years of follow-up
- (2014) Melinda E Sanders et al. MODERN PATHOLOGY
- Genome-wide DNA methylation profiles in progression to
- (2014) Thomas Fleischer et al. GENOME BIOLOGY
- Molecular subtypes in ductal carcinoma in situ of the breast and their relation to prognosis: a population-based cohort study
- (2013) Wenjing Zhou et al. BMC CANCER
- Altered Microenvironment Promotes Progression of Preinvasive Breast Cancer: Myoepithelial Expression of v 6 Integrin in DCIS Identifies High-risk Patients and Predicts Recurrence
- (2013) M. D. Allen et al. CLINICAL CANCER RESEARCH
- Ductal Carcinoma In Situ of the Breast: Can Biomarkers Improve Current Management?
- (2013) J. M. S. Bartlett et al. CLINICAL CHEMISTRY
- Clonal alteration of breast cancer receptors between primary ductal carcinoma in situ (DCIS) and corresponding local events
- (2013) E. Karlsson et al. EUROPEAN JOURNAL OF CANCER
- Stromal architecture and periductal decorin are potential prognostic markers for ipsilateral locoregional recurrence in ductal carcinomain situof the breast
- (2013) Mieke Van Bockstal et al. HISTOPATHOLOGY
- Breast-Conserving Treatment With or Without Radiotherapy in Ductal Carcinoma In Situ: 15-Year Recurrence Rates and Outcome After a Recurrence, From the EORTC 10853 Randomized Phase III Trial
- (2013) Mila Donker et al. JOURNAL OF CLINICAL ONCOLOGY
- A Multigene Expression Assay to Predict Local Recurrence Risk for Ductal Carcinoma In Situ of the Breast
- (2013) L. J. Solin et al. JNCI-Journal of the National Cancer Institute
- Predictors of recurrence for ductal carcinoma in situ after breast-conserving surgery
- (2013) John R Benson et al. LANCET ONCOLOGY
- Frequent phosphatidylinositol-3-kinase mutations in proliferative breast lesions
- (2013) Daphne C Ang et al. MODERN PATHOLOGY
- A Nation-Wide Multicenter Retrospective Study of the Epidemiological, Pathological and Clinical Characteristics of Breast Cancer In Situ in Chinese Women in 1999 - 2008
- (2013) Yanan Kong et al. PLoS One
- Biofunctional characteristics of in situ and invasive breast carcinoma
- (2013) Sara Bravaccini et al. CELLULAR ONCOLOGY
- Management of ductal carcinoma in situ according to Van Nuys Prognostic Index in Australia and New Zealand
- (2012) Robert Whitfield et al. ANZ JOURNAL OF SURGERY
- Use of trastuzumab in Australia and New Zealand: results from the National Breast Cancer Audit
- (2012) Robert Whitfield et al. ANZ JOURNAL OF SURGERY
- The penetrance of ductal carcinoma in situ among BRCA1 and BRCA2 mutation carriers
- (2012) Emanuele Mazzola et al. BREAST CANCER RESEARCH AND TREATMENT
- Gene expression profiling of tumour epithelial and stromal compartments during breast cancer progression
- (2012) Ana Cristina Vargas et al. BREAST CANCER RESEARCH AND TREATMENT
- HER2/neu and Ki-67 expression predict non-invasive recurrence following breast-conserving therapy for ductal carcinoma in situ
- (2012) E Rakovitch et al. BRITISH JOURNAL OF CANCER
- Differentially Expressed Genes Regulating the Progression of Ductal Carcinoma In Situ to Invasive Breast Cancer
- (2012) S. Lee et al. CANCER RESEARCH
- Genome-wide methylation screen in low-grade breast cancer identifies novel epigenetically altered genes as potential biomarkers for tumor diagnosis
- (2012) Marta Faryna et al. FASEB JOURNAL
- Evaluation of a Breast Cancer Nomogram for Predicting Risk of Ipsilateral Breast Tumor Recurrences in Patients With Ductal Carcinoma in Situ After Local Excision
- (2012) Min Yi et al. JOURNAL OF CLINICAL ONCOLOGY
- Genomic and mutational profiling of ductal carcinomas in situ and matched adjacent invasive breast cancers reveals intra-tumour genetic heterogeneity and clonal selection
- (2012) Lucia Hernandez et al. JOURNAL OF PATHOLOGY
- Sequence analysis of mutations and translocations across breast cancer subtypes
- (2012) Shantanu Banerji et al. NATURE
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA
- (2012) S. Volinia et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Biological Markers in DCIS and Risk of Breast Recurrence: A Systematic Review
- (2012) Sara A. Lari et al. Journal of Cancer
- Association of RB/p16-Pathway Perturbations with DCIS Recurrence
- (2011) Agnieszka K. Witkiewicz et al. AMERICAN JOURNAL OF PATHOLOGY
- Outcomes of Screening-Detected Ductal Carcinoma In Situ Treated with Wide Excision Alone
- (2011) Jonathan Fong et al. ANNALS OF SURGICAL ONCOLOGY
- Tumor characteristics as predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis
- (2011) Shi-Yi Wang et al. BREAST CANCER RESEARCH AND TREATMENT
- Second events following ductal carcinoma in situ of the breast: a register-based cohort study
- (2011) Ragnhild Sørum Falk et al. BREAST CANCER RESEARCH AND TREATMENT
- Identification of copy number alterations associated with the progression of DCIS to invasive ductal carcinoma
- (2011) Clint E. Johnson et al. BREAST CANCER RESEARCH AND TREATMENT
- Long-Term Outcomes of Invasive Ipsilateral Breast Tumor Recurrences After Lumpectomy in NSABP B-17 and B-24 Randomized Clinical Trials for DCIS
- (2011) I. L. Wapnir et al. JNCI-Journal of the National Cancer Institute
- Cells of origin in cancer
- (2011) Jane E. Visvader NATURE
- Ductal Carcinoma in Situ at Core-Needle Biopsy: Meta-Analysis of Underestimation and Predictors of Invasive Breast Cancer
- (2011) Meagan E. Brennan et al. RADIOLOGY
- Different Distribution of Breast Cancer Subtypes in Breast Ductal Carcinoma in situ (DCIS), DCIS with Microinvasion, and DCIS with Invasion Component
- (2010) Ke-Da Yu et al. ANNALS OF SURGICAL ONCOLOGY
- Molecular subtyping of DCIS: heterogeneity of breast cancer reflected in pre-invasive disease
- (2010) S E Clark et al. BRITISH JOURNAL OF CANCER
- Stromal CD10 and SPARC expression in ductal carcinoma in situ (DCIS) patients predicts disease recurrence
- (2010) Agnieszka K. Witkiewicz et al. CANCER BIOLOGY & THERAPY
- PIK3CA Mutations in In situ and Invasive Breast Carcinomas
- (2010) A. Miron et al. CANCER RESEARCH
- Breast cancer precursors revisited: molecular features and progression pathways
- (2010) Maria A Lopez-Garcia et al. HISTOPATHOLOGY
- Expression of metalloproteases and their inhibitors by tumor and stromal cells in ductal carcinoma in situ of the breast and their relationship with microinvasive events
- (2010) L. O. González et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Nomogram for Predicting the Risk of Local Recurrence After Breast-Conserving Surgery for Ductal Carcinoma In Situ
- (2010) Udo Rudloff et al. JOURNAL OF CLINICAL ONCOLOGY
- Biomarker Expression and Risk of Subsequent Tumors After Initial Ductal Carcinoma In Situ Diagnosis
- (2010) K. Kerlikowske et al. JNCI-Journal of the National Cancer Institute
- Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial
- (2010) Jack Cuzick et al. LANCET ONCOLOGY
- Genetic mutations and expression of p53 in non-invasive breast lesions
- (2010) Feng Jin Molecular Medicine Reports
- Molecular diversity in ductal carcinoma in situ (DCIS) and early invasive breast cancer
- (2010) Aslaug Aamodt Muggerud et al. Molecular Oncology
- PIK3CA mutations associated with gene signature of low mTORC1 signaling and better outcomes in estrogen receptor-positive breast cancer
- (2010) S. Loi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Promoter CpG island hypermethylation during breast cancer progression
- (2010) So Yeon Park et al. VIRCHOWS ARCHIV
- Gene amplification in ductal carcinoma in situ of the breast
- (2009) L. Burkhardt et al. BREAST CANCER RESEARCH AND TREATMENT
- Analysis of stromal signatures in the tumor microenvironment of ductal carcinoma in situ
- (2009) M. Sharma et al. BREAST CANCER RESEARCH AND TREATMENT
- PIK3CA Mutation Associates with Improved Outcome in Breast Cancer
- (2009) K. Kalinsky et al. CLINICAL CANCER RESEARCH
- Early and Locally Advanced Breast Cancer: Diagnosis and Treatment National Institute for Health and Clinical Excellence Guideline 2009
- (2009) J. Yarnold CLINICAL ONCOLOGY
- PIK3CA mutations mostly begin to develop in ductal carcinoma of the breast
- (2009) Hua Li et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
- (2009) Maggie C. U. Cheang et al. JNCI-Journal of the National Cancer Institute
- Role of COX-2 in epithelial-stromal cell interactions and progression of ductal carcinoma in situ of the breast
- (2009) M. Hu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- COX-2 and PPARγ expression are potential markers of recurrence risk in mammary duct carcinoma in-situ
- (2008) Swati Kulkarni et al. BMC CANCER
- Regulation of In Situ to Invasive Breast Carcinoma Transition
- (2008) Min Hu et al. CANCER CELL
- Molecular Grading of Ductal Carcinoma In situ of the Breast
- (2008) R. L. Balleine et al. CLINICAL CANCER RESEARCH
- Integrated Genomic and Transcriptomic Analysis of Ductal Carcinoma In situ of the Breast
- (2008) A. Vincent-Salomon et al. CLINICAL CANCER RESEARCH
- Ductal Carcinoma In situ and the Emergence of Diversity during Breast Cancer Evolution
- (2008) D. C. Allred et al. CLINICAL CANCER RESEARCH
- The significance of the Van Nuys prognostic index in the management of ductal carcinoma in situ
- (2008) Onur Gilleard et al. World Journal of Surgical Oncology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started